What is CG Oncology's free cash flow yield?

CG Oncology (CGON) reported free cash flow yield of -2.8% in Q1 2026.

How has CG Oncology's free cash flow yield changed year-over-year?

CG Oncology's free cash flow yield increased by 36.3% year-over-year, from -4.4% to -2.8%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

CG Oncology CGON Free cash flow yield

Free cash flow yield at other companies

PfizerPFE

7.8%+4.6pp

Johnson & JohnsonJNJ

3%-2.1pp

Gilead SciencesGILD

5.9%-1.1pp

ImmunityBio, Inc.IBRX

-3.8%-1.6pp

Cogent Biosciences, Inc.COGT

-4.6%-2.1pp

Tango TherapeuticsTNGX

-4.8%-2.3pp

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Calculated from CG Oncology’s reported figures.

free cash flow/market cap=-2.8%

Based on trailing twelve months.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's free cash flow yield?: CG Oncology (CGON) reported free cash flow yield of -2.8% in Q1 2026.
How has CG Oncology's free cash flow yield changed year-over-year?: CG Oncology's free cash flow yield increased by 36.3% year-over-year, from -4.4% to -2.8%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.